"The FDA tries really hard not to question the judgment of a prescriber," he said

Technical Information Compound Name: Melanotan II (MT-II) Chemical Classification: Synthetic Melanocortin Receptor Agonist Peptide Composition Melanotan II (MT-II) is a synthetic peptide analogue structurally related to -melanocyte-stimulating hormone (-MSH) and is commonly researched for its potential interaction with: Melanogenesis pathways Pigmentation-related signaling Melanocortin receptor activity Neuroendocrine mechanisms Peptide Characteristics Synthetic melanocortin receptor agonist peptide Pigmentation and melanogenesis research peptide Commonly researched for melanin-production and UV-response pathways Investigated for appetite-related and neuroendocrine signaling Frequently studied in behavioral-response and melanocortin-system research models Amino Acid Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH Molecular Formula: CHNO Molecular Weight: 1024.2 g/mol Appearance: White to off-white lyophilized powder Solubility: Water soluble Research Category: Melanocortin, pigmentation, and neuroendocrine research peptide Common Research Areas Pigmentation and melanogenesis research UV-response and pigmentation-adaptation studies Melanocortin receptor signaling investigations Appetite-related neuroregulatory pathways Behavioral-response and neuroendocrine research Central nervous system melanocortin studies Stability Melanotan II is typically supplied in lyophilized form to support peptide stability, purity, and long-term storage integrity during laboratory handling and research use

This medication is not made for resale, bulk, or distribution, and is compounded exclusively to meet the clinical needs of my individual patients under my care and supervision, and when commercially available alternatives are not appropriate.
Nature 517 , 497500 (2015)
Trustpilot 4.5/5 but BBB F
Key sources included the US Food & Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA) Japan, Medicines and Healthcare products Regulatory Agency (MHRA) UK, National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report, World Health Organization (WHO) Global Health Observatory, International Diabetes Federation (IDF) Diabetes Atlas, American Diabetes Association (ADA) Standards of Care, European Association for the Study of Diabetes (EASD) Guidelines, IQVIA Institute for Human Data Science, Evaluate Pharma, and national health ministry reports from key markets (China NMPA, India CDSCO, Brazil ANVISA)